Webinar

Join Advarra’s regulatory experts in another discussion of institutional and IRB responsibilities and dig deeper into the FWA topic.

Take a look at the role and function of independent DMCs from charter creation through interim data analysis to prepare your next trial.

Register for our webinar for a discussion on why it’s important to recruit diverse patients of all backgrounds.

June 15, 2021

In this webinar, we evaluate critical requirements and advanced workflows life sciences companies should look for in site training technology.

Learrn how to navigate thorny issues in medical device research, including which regulatory requirements apply to different types of device studies.

In this discussion, panelists provide actionable strategies for improving access to clinical research for diverse, underserved populations.

This webinar will discuss the importance of protocol feasibility and identifying solutions to ensure your organization's success.

Luke Gelinas, IRB Chairperson at Advarra, addresses ethical and practical issues involved with social media recruitment.

A Food and Drug Administration (FDA) inspection of a clinical investigator can occur at any time. The FDA conducts inspections of clinical investigators to verify clinical trial data submitted to FDA; to ensure that the rights, safety, and welfare of human subjects enrolled in FDA-regulated clinical trials are protected; and to assess regulatory compliance.

Effective remote monitoring plans enable sites and sponsors to maintain trial participant safety, data quality, and data integrity. With limited availability to access research sites in person over the past year, sponsors and monitors rapidly changed how they review study procedures, subject status, and study progress at research sites.

With comprehensive research portfolios and a myriad of operational challenges to manage, it has never been more important for sites to approach research operations as a business.